APA (7th ed.) Citation

Knox, J., McNamara, M., Goyal, L., Cosgrove, D., Springfeld, C., Sjoquist, K., . . . Valle, J. (2021). 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide: 121). Annals of Oncology, 32, S381. https://doi.org/10.1016/j.annonc.2021.08.338

Chicago Style (17th ed.) Citation

Knox, J., et al. "59TiP Phase III Study of NUC-1031 + Cisplatin Vs Gemcitabine + Cisplatin for First-line Treatment of Patients with Advanced Biliary Tract Cancer (NuTide: 121)." Annals of Oncology 32 (2021): S381. https://doi.org/10.1016/j.annonc.2021.08.338.

MLA (9th ed.) Citation

Knox, J., et al. "59TiP Phase III Study of NUC-1031 + Cisplatin Vs Gemcitabine + Cisplatin for First-line Treatment of Patients with Advanced Biliary Tract Cancer (NuTide: 121)." Annals of Oncology, vol. 32, 2021, p. S381, https://doi.org/10.1016/j.annonc.2021.08.338.